SEC Form 4 · accession 0001193125-26-354517
Tenaya Therapeutics, Inc. · TNYA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Whittemore Tingley
Officer — Chief Medical Officer
Period of report
Aug 17, 2026
Accepted (ET)
Aug 17, 2026 · 8:49 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001858848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Aug 17, 2026 | S | 1,637 | $0.7098 | D | 219,860 | D | |
| Common StockF2,F5 | Aug 17, 2026 | S | 1,637 | $0.7098 | D | 218,223 | D | |
| Common StockF2,F7 | Aug 17, 2026 | S | 1,871 | $0.7098 | D | 216,352 | D | |
| Common StockF2,F9 | Aug 17, 2026 | S | 2,279 | $0.7098 | D | 214,073 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023.
- F2Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F3Includes 108,544 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 6,000 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on June 10, 2026.
- F4Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024.
- F5Includes 104,169 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- F6Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025.
- F7Includes 99,169 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- F8Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 3, 2026.
- F9Includes 93,076 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.